Evaluating sirolimus‐based immunosuppression for the prevention of cytomegalovirus replication after liver transplantation

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-0012|29|9|723-723

ISSN： 0902-0063

Source： CLINICAL TRANSPLANTATION (ELECTRONIC), Vol.29, Iss.9, 2015-09, pp. : 723-723

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The effect of sirolimus‐based immunosuppression vs. conventional prophylaxis therapy on cytomegalovirus infection after liver transplantation

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 6, 2015-06 ,pp. : 555-559

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sirolimus-Based Immunosuppression in Kidney Transplantation for Type 2 Diabetic Nephropathy

By  

Urologia Internationalis, Vol. 84, Iss. 3, 2010-04 ,pp. : 301-304

Karger

Access to resources Recommend Favorite

Withdrawal of tacrolimus stabilizes TGF‐β

By  

NEPHROLOGY, Vol. 20, Iss. 3, 2015-03 ,pp. : 168-176

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of donor/recipient human leukocyte antigen mismatch on human cytomegalovirus replication following liver transplantation

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 1, 2015-02 ,pp. : 25-32

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk factors for cytomegalovirus reactivation after liver transplantation: Can pre‐transplant cytomegalovirus antibody titers predict outcome?

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 4, 2015-04 ,pp. : 539-546

John Wiley & Sons Inc

Access to resources Recommend Favorite